JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB283346

Anti-Iba1 抗体 [EPR16589] - Rat IgG2a (Chimeric)

Anti-Iba1 antibody [EPR16589] - Microglia marker - Rat IgG2a (Chimeric)

  • BOND RX™ Validated
  • Recombinant
  • Lab Essentials
  • 20ul selling size
  • 詳細を見る

5

(3 Reviews)

|

(38 Publications)

Anti-Iba1 antibody [EPR16589] - Rat IgG2a (Chimeric) (ab283346) is a rat monoclonal antibody detecting Iba1 in Western Blot, Flow Cytometry (Intra), IP, IHC-P, ICC/IF. Suitable for Human, Mouse, Rat.

- Biophysical QC for unrivalled batch-batch consistency

別名を表示する

G1, IBA1, AIF1, Allograft inflammatory factor 1, AIF-1, Ionized calcium-binding adapter molecule 1, Protein G1, iba1, iba-1, iba 1

8 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Iba1 antibody [EPR16589] - Microglia marker - Rat IgG2a (Chimeric) (AB283346)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Iba1 antibody [EPR16589] - Microglia marker - Rat IgG2a (Chimeric) (AB283346)

Immunohistochemical analysis of paraffin-embedded rat cerebrum tissue labeling Iba1 with ab283346 at 1/5000 (0.173 μg/ml) dilution followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining on the microglia in rat cerebrum. The section was incubated with ab283346 for 10 mins at room temperature and followed by rat IgG antibody (ab102248) for 8 mins. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.

Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).

Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Iba1 antibody [EPR16589] - Microglia marker - Rat IgG2a (Chimeric) (AB283346)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Iba1 antibody [EPR16589] - Microglia marker - Rat IgG2a (Chimeric) (AB283346)

Immunohistochemical analysis of paraffin-embedded human cerebrum tissue labeling Iba1 with ab283346 at 1/5000 (0.173 μg/ml) dilution followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining on the microglia in human cerebrum. The section was incubated with ab283346 for 10 mins at room temperature and followed by rat IgG antibody (ab102248) for 8 mins. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.

Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).

Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins.

Immunocytochemistry/ Immunofluorescence - Anti-Iba1 antibody [EPR16589] - Microglia marker - Rat IgG2a (Chimeric) (AB283346)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-Iba1 antibody [EPR16589] - Microglia marker - Rat IgG2a (Chimeric) (AB283346)

Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized THP-1 cells labelling Iba1 with ab283346 at 1/100 (8.63 μg/ml) dilution, followed by ab150157 Goat Anti-Rat IgG H&L (Alexa Fluor® 488) antibody at 1/1000 dilution (Green). Confocal image showing cytoplasmic staining in THP-1 cells. ab179513 Anti-beta Tubulin rabbit monoclonal antibody was used to counterstain tubulin at 1/200 dilution, followed by ab150080 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 594) at a 1/1000 dilution (Red). The nuclear counterstain was DAPI (Blue).

Negative control cell line : MCF7.

-ve control 1 : ab283346 at 1/100 dilution followed by ab150080 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 594) at a 1/1000 dilution.

-ve control 2 : ab179513 Anti-beta Tubulin rabbit monoclonal antibody at a 1/200 dilution followed by ab150157 Goat Anti-Rat IgG H&L (Alexa Fluor® 488) antibody at 1/1000 dilution.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Iba1 antibody [EPR16589] - Microglia marker - Rat IgG2a (Chimeric) (AB283346)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Iba1 antibody [EPR16589] - Microglia marker - Rat IgG2a (Chimeric) (AB283346)

Immunohistochemical analysis of paraffin-embedded human endometrium tissue labeling Iba1 with ab283346 at 1/5000 (0.173 μg/ml) dilution followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining on the immune cells in human endometrium. The section was incubated with ab283346 for 10 mins at room temperature and followed by rat IgG antibody (ab102248) for 8 mins. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.

Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).

Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins.

Flow Cytometry (Intracellular) - Anti-Iba1 antibody [EPR16589] - Microglia marker - Rat IgG2a (Chimeric) (AB283346)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-Iba1 antibody [EPR16589] - Microglia marker - Rat IgG2a (Chimeric) (AB283346)

Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized MCF7 (Human breast adenocarcinoma epithelial cell, Left) / THP-1 (Human monocytic leukemia monocyte, Right) cells labelling Iba1 with ab283346 at 1/10000 dilution (0.01 μg) (Red) compared with a Rat monoclonal IgG (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat F(ab)2 Anti-Rat IgG Fc (Alexa Fluor® 488, ab150161) at 1/2000 dilution was used as the secondary antibody.

Negative control : MCF7.

Immunoprecipitation - Anti-Iba1 antibody [EPR16589] - Microglia marker - Rat IgG2a (Chimeric) (AB283346)
  • IP

Supplier Data

Immunoprecipitation - Anti-Iba1 antibody [EPR16589] - Microglia marker - Rat IgG2a (Chimeric) (AB283346)

Iba1 was immunoprecipitated from 0.35 mg THP-1 (human monocytic leukemia monocyte), whole cell lysate 10 μg with ab283346 at 1/30 dilution (2 μg in 0.35 mg lysates). Western blot was performed on the immunoprecipitate using ab283346 at 1/1000 dilution. Goat Anti-Rat IgG (H+L), HRP) (ab205720) was used at 1/10000 dilution.

Lane 1 : THP-1 whole cell lysate 10 μg

Lane 2 : ab283346 IP in THP-1 whole cell lysate

Lane 3 : Rat monoclonal IgG (ab18450) instead of ab283346 in THP-1 whole cell lysate

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 1 second.

All lanes:

Immunoprecipitation - Anti-Iba1 antibody [EPR16589] - Microglia marker - Rat IgG2a (Chimeric) (ab283346)

Predicted band size: 16 kDa

Observed band size: 16 kDa

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Iba1 antibody [EPR16589] - Microglia marker - Rat IgG2a (Chimeric) (AB283346)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Iba1 antibody [EPR16589] - Microglia marker - Rat IgG2a (Chimeric) (AB283346)

Immunohistochemical analysis of paraffin-embedded mouse cerebrum tissue labeling Iba1 with ab283346 at 1/5000 (0.173 μg/ml) dilution followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining on the microglia in mouse cerebrum. The section was incubated with ab283346 for 10 mins at room temperature and followed by rat IgG antibody (ab102248) for 8 mins. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.

Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).

Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins.

Western blot - Anti-Iba1 antibody [EPR16589] - Microglia marker - Rat IgG2a (Chimeric) (AB283346)
  • WB

Supplier Data

Western blot - Anti-Iba1 antibody [EPR16589] - Microglia marker - Rat IgG2a (Chimeric) (AB283346)

Blocking and diluting buffer : 5% NFDM/TBST

Negative control : MCF7 (HPA database)

Exposure time : 37 seconds

All lanes:

Western blot - Anti-Iba1 antibody [EPR16589] - Microglia marker - Rat IgG2a (Chimeric) (ab283346) at 1/1000 dilution

Lane 1:

THP-1 (human monocytic leukemia monocyte), whole cell lysate at 20 µg

Lane 2:

MCF7 (human breast adenocarcinoma epithelial cell), whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rat IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rat-igg-h-l-hrp-ab205720'>ab205720</a>) at 1/5000 dilution

Predicted band size: 16 kDa

Observed band size: 16 kDa

false

関連する標識済み抗体及び組成の異なる製品 (1)

  • Carrier free

    Anti-Iba1 antibody [EPR16589] - Mouse IgG1 (Chimeric) - BSA and Azide free

Key facts

宿主種

Rat

クローン性

Monoclonal

クローン番号

EPR16589

アイソタイプ

IgG2a

キャリアフリー

No

交差種

Human, Mouse, Rat

アプリケーション

WB, Flow Cyt (Intra), IP, IHC-P, ICC/IF

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/5000", "IHCP-species-notes": "<p>Not recommended for use with fluorescent secondary antibodies in mouse and rat IHC-P applications.</p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100", "ICCIF-species-notes": "<p></p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/10000", "FlowCytIntra-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/5000", "IHCP-species-notes": "<p>Not recommended for use with fluorescent secondary antibodies in mouse and rat IHC-P applications.</p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" }, "Rat": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/5000", "IHCP-species-notes": "<p>Not recommended for use with fluorescent secondary antibodies in mouse and rat IHC-P applications.</p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

製品の詳細

Find all reagents to label astrocytes in our "Microglia markers guide".

Product Specifications
Anti-Iba1 antibody [EPR16589] - Rat IgG2a (Chimeric) (ab283346) is a rat monoclonal recombinant antibody validated for use in IHC-P, IP, WB, ICC/IF and Flow Cyt (Intra) in mouse, rat and human samples.
Clone EPR16589 was initially developed by Abcam using patented rabbit monoclonal antibody technology and has been engineered to generate this rat chimeric antibody which retains the binding properties of the RabMAb parent, but has a rat Fc region. By necessity, some rabbit sequence is retained as part of the variable domain. When multiplexing with other rabbit-derived antibodies, using cross absorbed Fc-reactive secondary antibodies are recommended.
Anti-Iba1 antibody [EPR16589] - Rat IgG2a (Chimeric) (ab283346) specifically detects Iba1 (AIF-1) (UniProt ID: P55008; Molecular weight: 17kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL).

Quality and Validation
Abcams high quality manufacturing and validation processes ensure Anti-Iba1 antibody [EPR16589] - Rat IgG2a (Chimeric) (ab283346) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.

Target Information
Iba1 (Ionized calcium-binding adapter molecule 1; allograft inflammatory factor 1, AIF1) is a prominent microglial marker extensively used in neuroscience research. Its expression increases in various neurodegenerative conditions, including Alzheimer's disease (AD), indicating microglial activation and neuroinflammation. Researchers utilize Iba1 in stainings to assess microglial response and activity in different models, making it essential for understanding inflammatory processes in the brain. Changes in Iba1 expression provide valuable insights into neuroinflammation, highlighting its importance in studying diseases like AD.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Ion exchange chromatography
バッファー組成
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

Iba1 also known as Allograft Inflammatory Factor 1 (AIF-1) is a 17 kDa protein notable for its involvement in immune responses. It is expressed mainly in microglia and macrophages key components of the central nervous system's immune system. Researchers often use Iba1 in Western blots and immunohistochemistry (IHC) to study microglial activation. The protein's expression is a strong marker of microglial activation making it a focal point in neuroinflammation studies. Anti-Iba1 antibodies have gained popularity for their effectiveness in identifying microglia in brain tissue sections through Iba1 staining techniques.
Biological function summary

Iba1 modulates actin bundling facilitating changes in microglial morphology and motility. It does not form part of a multiprotein complex but is significantly involved in cytoskeletal dynamics. This protein's expression increases during brain injury indicating its role in response to neural trauma. Iba1 has calcium-binding properties which suggest that it might interact with proteins involved in calcium signaling pathways.

Pathways

Calcium signaling and actin cytoskeletal rearrangement are significant biological processes that involve Iba1. Within these pathways Iba1 interacts closely with other actin-binding proteins that affect microglial movement and morphology. Such interactions illustrate how Iba1 helps microglia navigate and respond to changes within the brain environment.

Iba1 is often associated with neurodegenerative diseases like Alzheimer's disease and amyotrophic lateral sclerosis (ALS). In these conditions elevated Iba1 levels mark increased microglial activity which correlates with disease progression. Connections with proteins such as amyloid-beta in Alzheimer's disease suggest its role in mediating inflammatory responses and linking inflammation to disease pathology.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Actin-binding protein that enhances membrane ruffling and RAC activation. Enhances the actin-bundling activity of LCP1. Binds calcium. Plays a role in RAC signaling and in phagocytosis. May play a role in macrophage activation and function. Promotes the proliferation of vascular smooth muscle cells and of T-lymphocytes. Enhances lymphocyte migration. Plays a role in vascular inflammation.
See full target information AIF1

文献 (38)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in pharmacology 16:1574007 PubMed41050410

2025

Rational design of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors featuring 1,2,3-triazole derivatives with enhanced anti-inflammatory and analgesic efficacy.

Applications

Unspecified application

Species

Unspecified reactive species

Qingying Liu,Xixi Hou,Yueliang Wang,Mingyue Tian,Baoyu He,Jingjing Guo,Jianxue Yang

Cell reports. Medicine 6:102319 PubMed40882623

2025

Selenized neural stem cell-derived exosomes: A neotype therapeutic agent for traumatic injuries of the central nervous system.

Applications

Unspecified application

Species

Unspecified reactive species

Wenjing Wang,Guihong Lu,Peilin Guo,Haochong Zhang,Yan Wang,Diwei Zheng,Chengliang Lyu,Dongfang Wang,Shang Li,Feng Li,Jiawei Zhao,Meng Qin,Weiping Li,Hui Tan,Guanghui Ma,Wei Wei

Science advances 11:eadw0730 PubMed40802746

2025

Lipid nanoparticles for mRNA delivery in brain via systemic administration.

Applications

Unspecified application

Species

Unspecified reactive species

Dinglingge Cao,Xucheng Hou,Chang Wang,Siyu Wang,Zhengwei Liu,Meng Tian,Kaiyuan Guo,Haoyuan Li,Diana D Kang,Yichen Zhong,Yonger Xue,Changyue Yu,Binbin Deng,Yizhou Dong

Journal of biomedical research :1-14 PubMed40770862

2025

HDGF derived from Müller cells enhances the activation of microglia in diabetic retinopathy.

Applications

Unspecified application

Species

Unspecified reactive species

Aowang Qiu,Wenjie Yin,Ningyu Wang,Xin Wang,Qinghuai Liu,Weiwei Zhang

Zoological research 46:877-892 PubMed40709531

2025

Anatomical mapping of GFAP-immunoreactive astrocytes in the tree shrew brain.

Applications

Unspecified application

Species

Unspecified reactive species

Ya-Tao Wang,Qi-Qi Xu,Shuo-Wen Wang,Jin-Kun Guo,Shuai-Deng Wang,Xin-Ya Qin,Qing-Hong Shan,Yu Wang,Rong-Yu Liu,Yue-Xiong Yang,Chen-Wei Wang,Peng Chen,Jiang-Ning Zhou

Molecular neurobiology 62:13430-13448 PubMed40536592

2025

VISTA Alleviates Microglia-Mediated Neuroinflammation After Cerebral Ischemia-Reperfusion Injury via Regulating ACOD1/Itaconic Acid Metabolism.

Applications

Unspecified application

Species

Unspecified reactive species

Yilei Sun,Dan Liu,Yanchen Liu,Lijun Chi

Nature communications 16:4318 PubMed40346081

2025

Ectoparasites enhance survival by suppressing host exploration and limiting dispersal.

Applications

Unspecified application

Species

Unspecified reactive species

Pengbo Liu,Dongsheng Ren,Guichang Li,Xiaoming Xu,Luca Presotto,Wei Liu,Ning Zhao,Dongmei Li,Min Chen,Jun Wang,Xiaobo Liu,Chunchun Zhao,Liang Lu,Qiyong Liu

Acta neuropathologica communications 13:86 PubMed40307956

2025

Prion replication in organotypic brain slice cultures is distinct from in vivo inoculation and is species dependent.

Applications

Unspecified application

Species

Unspecified reactive species

Jessy A Slota,Lise Lamoureux,Jennifer Myskiw,Kathy L Frost,Sarah J Medina,Dominic M S Kielich,Melanie Leonhardt,Gunjan Thapar,Ben A Bailey-Elkin,Stephanie A Booth

Inflammation 48:3487-3505 PubMed40261458

2025

4,4'-Dimethoxychalcone Mitigates Neuroinflammation Following Traumatic Brain Injury Through Modulation of the TREM2/PI3K/AKT/NF-κB Signaling Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Mengran Wang,Rui Zhao,Yue Su,Duhuan Zhai,Hengyan Liang,Lingkun Zhang,Weicheng Wang,Zhichun Wang,Min Qi,Xiaochun Jiang,Shizhang Ling,Guangfu Di

International journal of molecular sciences 26: PubMed40243488

2025

Clec7a Signaling in Microglia Promotes Synapse Loss Associated with Tauopathy.

Applications

Unspecified application

Species

Unspecified reactive species

Shubing Yang,Ji Wang,Yongkang Cao,Yibo Zhang,Zhuoran Sun,Pin Wan,Mingshan Pi,Qi Xiong,Xiji Shu,Xiaochuan Wang,Yiyuan Xia
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com